It's a Pity They Didn't Wait?

The countries, who stopped delivering the Oxford/AstraZeneca vaccine, citing 'an excess of caution', seem to have acted inappropriately. A very large US trial with participants in America, Chile and Peru is now added to the already substantial body of data on the vaccine. This US study, shows the vaccine has 79% effectiveness and does not increase blood clotting risk (https://www.theguardian.com/society/2021/mar/22/astrazeneca-covid-vaccine-79-effective-with-no-increased-blood-clot-risk-us-trial). Indeed, in the US study, the Oxford/AstraZeneca vaccine was 100% effective, in protecting against severe or critical disease. A separate analysis by AstraZeneca, on more than 21.5k people, who had received a first dose of the vaccine, also found no increased risk of thrombosis. It's a great pity there was a delay, getting this vaccine into arms. The impression is certainly given, that the nations pausing their roll-outs of the Oxford/AstraZeneca vaccine, didn't weigh the evidence fairly. Political point scoring seems to have trumped public health?